XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise

April 30, 2026 11:13 AM EDT Manufacturing XTL Bio to ac­quire psy­che­del­ic biotech; WuXi AppTec’s Q1 rev­enue rise Anna Brown News Reporter Plus, news about PCI Phar­ma: 🏭 XTL Bio steps in­to psy­che­delics: XTL Bio­phar­ma­ceu­ti­cals is ac­quir­ing 100% of the out­stand­ing shares of … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER